lab on a chip

According to a recent BT report, the VereCoV detection kit is expected to be commercially available by Feb 1 this year.

Theranos, the 12-year-old Palo Alto-based company working on a smaller, cheaper, alternative to common lab blood tests, has received its first voluntary FDA 510(k) clearance, for its herpes simplex 1 virus IgG (HSV IgG) test.